Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-02

Clinical Trial Update: Targeting ATR in Soft-tissue Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating an ATR-targeting therapy for adult leiomyosarcoma; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATR inhibitor

Snippet

Sponsor: Institut Bergonié | Conditions: Leiomyosarcoma, Adult | Phase 2 | Status: RECRUITING